Khan Haseena, McDonald Megan C, Williams Simon J, Solomon Peter S
Division of Plant Sciences, Research School of Biology, The Australian National University, Canberra, 2601 Australia.
Fungal Biol Biotechnol. 2020 Mar 31;7:4. doi: 10.1186/s40694-020-00094-0. eCollection 2020.
The genome-editing tool CRISPR/Cas9 has revolutionized gene manipulation by providing an efficient method to generate targeted mutations. This technique deploys the Cas9 endonuclease and a guide RNA (sgRNA) which interact to form a Cas9-sgRNA complex that initiates gene editing through the introduction of double stranded DNA breaks. We tested the efficacy of the CRISPR/Cas9 approach as a means of facilitating a variety of reverse genetic approaches in the wheat pathogenic fungus .
protoplasts were transformed with the Cas9 protein and sgRNA in the form of a preassembled ribonuclear protein (RNP) complex targeting the effector gene. Subsequent screening of the transformants revealed 100% editing of those mutants screened. We further tested the efficacy of RNP complex when co-transformed with a -Homology Directed Repair cassette harbouring 1 kb of homologous flanking DNA. Subsequent screening of resulting transformants demonstrated homologous recombination efficiencies exceeding 70%. A further transformation with a -Homology Directed Repair cassette harbouring a selectable marker with 50 bp micro-homology flanks was also achieved with 25% homologous recombination efficiency. The success of these homology directed repair approaches demonstrate that CRISPR/Cas9 is amenable to other in vivo DNA manipulation approaches such as the insertion of DNA and generating point mutations.
These data highlight the significant potential that CRISPR/Cas9 has in expediting transgene-free gene knockouts in and also in facilitating other gene manipulation approaches. Access to these tools will significantly decrease the time required to assess the requirement of gene for disease and to undertake functional studies to determine its role.
基因组编辑工具CRISPR/Cas9通过提供一种产生靶向突变的有效方法,彻底改变了基因操作。该技术利用Cas9核酸内切酶和引导RNA(sgRNA),二者相互作用形成Cas9-sgRNA复合物,通过引入双链DNA断裂来启动基因编辑。我们测试了CRISPR/Cas9方法作为促进小麦致病真菌中多种反向遗传方法手段的有效性。
原生质体用靶向效应基因的预组装核糖核蛋白(RNP)复合物形式的Cas9蛋白和sgRNA进行转化。随后对转化体的筛选显示,所筛选的那些突变体的编辑率为100%。我们进一步测试了RNP复合物与携带1 kb同源侧翼DNA的同源定向修复盒共转化时的有效性。对所得转化体的后续筛选表明同源重组效率超过70%。用携带具有50 bp微同源侧翼的选择标记的同源定向修复盒进行的进一步转化也获得了25%的同源重组效率。这些同源定向修复方法的成功表明,CRISPR/Cas9适用于其他体内DNA操作方法,如DNA插入和产生点突变。
这些数据突出了CRISPR/Cas9在加速小麦中无转基因基因敲除以及促进其他基因操作方法方面的巨大潜力。使用这些工具将显著减少评估基因对疾病的需求以及进行功能研究以确定其作用所需的时间。